In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 6, 2009, Pages 958-965

  Dedeurwaerdere, Stefanie ^a,b   Gregoire, Marie Claude ^b   Vivash, Lucy ^a   Roselt, Peter ^c   Binns, David ^c   Fookes, Christopher ^b   Greguric, Ivan ^b   Pham, Tien ^b   Loc'H, Christian ^b   Katsifis, Andrew ^b   Hicks, Rodney J ^c   O'Brien, Terence J ^a   Myers, Damian E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Flumazenil; GABAA cBZ receptor; PET; Radioligand; Rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL; FLUMAZENIL F 18; FLUOROFLUMAZENIL F 18; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG BINDING; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG UPTAKE; EX VIVO STUDY; FLUORINATION; HIPPOCAMPUS; IN VIVO STUDY; MALE; MOLECULAR IMAGING; NONHUMAN; PONS; POSITRON EMISSION TOMOGRAPHY; RAT; SIGNAL NOISE RATIO;

ANIMALS; AUTORADIOGRAPHY; BRAIN; FLUMAZENIL; FLUORINE RADIOISOTOPES; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; REPRODUCIBILITY OF RESULTS;

EID: 67349105590     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1066-4     Document Type: Article

References (14)

1. W Haefely 1983 Antagonists of benzodiazepines: functional aspects Adv Biochem Psychopharmacol 38 73 93
2. P Leveque D Labar B Gallez 2001 Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents Nucl Med Biol 28 7 809 814
3. G Grunder T Siessmeier C Lange-Asschenfeldt I Vernaleken HG Buchholz P Stoeter 2001 [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors Eur J Nucl Med 28 10 1463 1470
4. M Mitterhauser W Wadsak L Wabnegger L-K Mien S Togel O Langer 2004 Biological evaluation of 2-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET Nucl Med Biol 31 2 291 295
5. YS Chang JM Jeong YH Yoon WJ Kang SJ Lee DS Lee 2005 Biological properties of 2-[18F]fluoroflumazenil for central benzodiazepine receptor imaging Nucl Med Biol 32 3 263 268
6. NN Ryzhikov N Seneca RN Krasikova NA Gomzina E Shchukin OS Fedorova 2005 Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography Nucl Med Biol 32 2 109 116
7. YH Yoon JM Jeong HW Kim SH Hong YS Lee HS Kil 2003 Novel one-pot one-step synthesis of 2-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging Nucl Med Biol 30 5 521 527
8. MC Huisman S Reder AW Weber SI Ziegler M Schwaiger 2007 Performance evaluation of the Philips MOSAIC small animal PET scanner Eur J Nucl Med Mol Imaging 34 4 532 540
9. JW Mandema JM Gubbens-Stibbe M Danhof 1991 Stability and pharmacokinetics of flumazenil in the rat Psychopharmacology (Berl) 103 3 384 387
10. J Hilton F Yokoi RF Dannals HT Ravert Z Szabo DF Wong 2000 Column-switching HPLC for the analysis of plasma in PET imaging studies Nucl Med Biol 27 6 627 630
11. C Halldin S Stone-Elander J-O Thorell A Persson G Sedvall 1988 11C-Labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors Appl Radiat Isot 39 9 993 997
12. SS Zoghbi HU Shetty M Ichise M Fujita M Imaizumi JS Liow 2006 PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements J Nucl Med 47 3 520 527
13. TJ Tewson MJ Welch 1980 Preparation and preliminary biodistribution of "no carrier added" fluorine-18 fluoroethanol J Nucl Med 21 6 559 564
14. B Kleingeist R Bocker G Geisslinger R Brugger 1998 Isolation and pharmacological characterization of microsomal human liver flumazenil carboxylesterase J Pharm Pharm Sci 1 1 38 46